Friday, July 21, 2017
Home Tags Clinical trials

Tag: clinical trials

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) Gains 19.66% As Phase 2 Trials...

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is engaged within the research, development, and commercialization of cancer treatments. Shares of the cancer treatment developer gained 19.66%,...

Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) Gains 6.22% After Completing Phase 2...

Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) operates as a clinical stage biopharmaceutical company, which develops treatments for a variety of ailments and diseases. Shares of...

Advanced Medical Isotope Corp. (OTC Pink: ADMD) Rallies 10% After Providing...

Advanced Medical Isotope Corp. (OTC Pink: ADMD) is engaged within the research, production, and distribution of medical isotopes. Shares of the medical company are...

SIGA Technologies, Inc. (OTC Pink: SIGA) Increases 8.92% After Completing Enrollment...

SIGA Technologies, Inc. (OTC Pink: SIGA) specializes in the development, testing, and commercialization of unmet medical needs and bio-threats. Its flagship drug, TPOXX, is...

BioCorRx, Inc. (OTCQB: BICX) Drops 28.26% Files Pre-IND Meeting Request with...

BioCorRx, Inc. (OTCQB: BICX) is engaged as a substance abuse treatment company. Shares of the rehabilitation and treatment company are diving 28.26%, through afternoon...

Aytu BioScience, Inc. (OTCQX: AYTU) Declines 6.02% After Announcing The Latest...

Aytu BioScience, Inc. (OTCQX: AYTU) is engaged as a specialty pharmaceutical company, which focuses on urology treatments. Shares of the specialty pharmaceutical company are...

Benitec Biopharma Ltd. (OTC Pink: BNIKF) Jumps 96.15% After Pre-Clinical Efficacy...

Benitec Biopharma Ltd. (OTC Pink: BNIKF) is a biotechnology company that focuses on the development of therapeutic treatments from patented gene-silencing technology. Shares of...

Oncolytics Biotech, Inc. (OTCQX: ONCYF) Jumps 26.13% After Positive Phase 2...

Oncolytics Biotech, Inc. (OTCQX: ONCYF) is a biotechnology company that focuses on developing treatments to treat tumors, cancers, and other diseases. The company’s flagship...

Cellceutix Corporation (OTCQB: CTIX) Gains 5.95% After Promising Phase 2 Clinical...

Cellceutix Corporation (OTCQB: CTIX) is a clinical stage biopharmaceutical company, which is working on six pharmaceutical compounds to treat a wide variety of diseases,...